Literature DB >> 11722323

Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men.

E A Osuch1, G Cora-Locatelli, M A Frye, T Huggins, T A Kimbrell, T A Ketter, A M Callahan, R M Post.   

Abstract

OBJECTIVE: Previous studies show a state-dependent relationship between depression and post-dexamethasone suppression test (DST) cortisol level, as well as differences in DST response with age and gender.
METHOD: In this study, 74 research in-patients with affective disorders were given the DST on placebo and in a subgroup following treatment with carbamazepine. Depression was evaluated twice daily with the Bunney-Hamburg (BH) rating scale. Data were examined for the total subject population, by gender and by menopausal status in women.
RESULTS: A robust positive correlation was observed between depression severity and post-DST cortisol in pre- and postmenopausal females, but not in males. This relationship persisted in women when restudied on a stable dose of carbamazepine (n=42).
CONCLUSION: The pathophysiological implications of this selective positive relationship between severity of depression and post-DST cortisol in women, but not men, should be explored further.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722323     DOI: 10.1034/j.1600-0447.2001.00395.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

Review 1.  Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.

Authors:  Robert M Post; Terence A Ketter; Thomas Uhde; James C Ballenger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  Long-term imipramine treatment affects rat brain and pituitary corticosteroid receptors and heat shock proteins levels in a gender-specific manner.

Authors:  I Elaković; J Brkljacić; G Matić
Journal:  J Neural Transm (Vienna)       Date:  2007-03-29       Impact factor: 3.575

3.  Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder.

Authors:  Gabriel Rodrigo Fries; Mirela Paiva Vasconcelos-Moreno; Carolina Gubert; Bárbara Tietböhl Martins Quadros dos Santos; Juliana Sartori; Bárbara Eisele; Pamela Ferrari; Adam Fijtman; Joëlle Rüegg; Nils Christian Gassen; Flávio Kapczinski; Theo Rein; Márcia Kauer-Sant'Anna
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.